Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1977 Apr;11(4):609–614. doi: 10.1128/aac.11.4.609

Netilmicin and Gentamicin: Comparative Pharmacology in Humans

Louise J Riff *, Gail Moreschi 1
PMCID: PMC352037  PMID: 856012

Abstract

Thirteen male subjects received 1 mg of either gentamicin or netilmicin per kg, first intramuscularly and then intravenously. After the intramuscular dose, concentrations of gentamicin in the serum were more variable than those of netilmicin. After the intravenous dose, the distribution phase of netilmicin was twice as rapid as gentamicin. The average half-times of the elimination phase were similar, but there was marked variability among the subjects receiving gentamicin. Serum clearance of netilmicin was more rapid than that of gentamicin and could not be attributed to renal elimination. The data indicate that, after intramuscular administration, netilmicin may produce more predictable blood levels than gentamicin and suggest that the body distribution of netilmicin may differ from that of gentamicin.

Full text

PDF
609

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AGGELER P. M., HOAG M. S., WALLERSTEIN R. O., WHISSELL D. The mild hemophilias. Occult deficiencies of AHF, PTC and PTA frequently responsible for unexpected surgical bleeding. Am J Med. 1961 Jan;30:84–94. doi: 10.1016/0002-9343(61)90065-1. [DOI] [PubMed] [Google Scholar]
  2. Barza M., Brown R. B., Shen D., Gibaldi M., Weinstein L. Predictability of blood levels of gentamicin in man. J Infect Dis. 1975 Aug;132(2):165–174. doi: 10.1093/infdis/132.2.165. [DOI] [PubMed] [Google Scholar]
  3. Bell W. R. Editorial: Thrombocytopenia occurring during heparin therapy. N Engl J Med. 1976 Jul 29;295(5):276–277. doi: 10.1056/NEJM197607292950511. [DOI] [PubMed] [Google Scholar]
  4. Bell W. R., Tomasulo P. A., Alving B. M., Duffy T. P. Thrombocytopenia occurring during the administration of heparin. A prospective study in 52 patients. Ann Intern Med. 1976 Aug;85(2):155–160. doi: 10.7326/0003-4819-85-2-155. [DOI] [PubMed] [Google Scholar]
  5. Clarke J. T., Libke R. D., Regamey C., Kirby W. M. Comparative pharmacokinetics of amikacin and kanamycin. Clin Pharmacol Ther. 1974 Jun;15(6):610–616. doi: 10.1002/cpt1974156610. [DOI] [PubMed] [Google Scholar]
  6. Flournoy D. J. Sisomicin versus netilmicin: in vitro susceptibility testing. Antimicrob Agents Chemother. 1976 Nov;10(5):864–865. doi: 10.1128/aac.10.5.864. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Fu K. P., Neu H. C. In vitro study of netilmicin compared with other aminoglycosides. Antimicrob Agents Chemother. 1976 Sep;10(3):526–534. doi: 10.1128/aac.10.3.526. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Fu K. P., Neu H. C. In vitro synergistic effect of netilmicin, a new aminoglycoside antibiotic. Antimicrob Agents Chemother. 1976 Sep;10(3):511–518. doi: 10.1128/aac.10.3.511. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Galioto G. B., Grassi C., Manara G., Santarelli P. Studies on tolerance and blood levels of gentamicin in old subjects. Int J Clin Pharmacol. 1974 Sep;10(2):95–100. [PubMed] [Google Scholar]
  10. Goodman E. L., Van Gelder J., Holmes R., Hull A. R., Sanford J. P. Prospective comparative study of variable dosage and variable frequency regimens for administration of gentamicin. Antimicrob Agents Chemother. 1975 Oct;8(4):434–438. doi: 10.1128/aac.8.4.434. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Greenblatt D. J., Koch-Weser J. Clinical pharmacokinetics (second of two parts). N Engl J Med. 1975 Nov 6;293(19):964–970. doi: 10.1056/NEJM197511062931905. [DOI] [PubMed] [Google Scholar]
  12. Hull J. H., Sarubbi F. A., Jr Gentamicin serum concentrations: pharmacokinetic predictions. Ann Intern Med. 1976 Aug;85(2):183–189. doi: 10.7326/0003-4819-85-2-183. [DOI] [PubMed] [Google Scholar]
  13. Kabins S. A., Nathan C., Cohen S. In vitro comparison of netilmicin, a semisynthetic derivative of sisomicin, and four other aminoglycoside antibiotics. Antimicrob Agents Chemother. 1976 Jul;10(1):139–145. doi: 10.1128/aac.10.1.139. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Kaye D., Levison M. E., Labovitz E. D. The unpredictability of serum concentrations of gentamicin: pharmacokinetics of gentamicin in patients with normal and abnormal renal function. J Infect Dis. 1974 Aug;130(2):150–154. doi: 10.1093/infdis/130.2.150. [DOI] [PubMed] [Google Scholar]
  15. Marks M. I., Hammerberg S., Greenstone G., Silver B. Activity of newer aminoglycosides and carbenicillin, alone and in combination, against gentamicin-resistant Pseudomonas aeruginosa. Antimicrob Agents Chemother. 1976 Sep;10(3):399–401. doi: 10.1128/aac.10.3.399. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Mendelson J., Portnoy J., Dick V., Black M. Safety of the bolus administration of gentamicin. Antimicrob Agents Chemother. 1976 Apr;9(4):633–638. doi: 10.1128/aac.9.4.633. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Noone P., Parsons T. M., Pattison J. R., Slack R. C., Garfield-Davies D., Hughes K. Experience in monitoring gentamicin therapy during treatment of serious gram-negative sepsis. Br Med J. 1974 Mar 16;1(5906):477–481. doi: 10.1136/bmj.1.5906.477. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Rahal J. J., Jr, Simberkoff M. S., Kagan K., Moldover N. H. Bactericidal efficacy of Sch 20569 and amikacin against gentamicin-sensitive and -resistant organisms. Antimicrob Agents Chemother. 1976 Apr;9(4):595–599. doi: 10.1128/aac.9.4.595. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Riff L. J., Jackson G. G. Pharmacology of gentamicin in man. J Infect Dis. 1971 Dec;124 (Suppl):S98–105. doi: 10.1093/infdis/124.supplement_1.s98. [DOI] [PubMed] [Google Scholar]
  20. SCHRIFTMAN H., KONDRITZER A. A. Absorption of atropine from muscle. Am J Physiol. 1957 Dec;191(3):591–594. doi: 10.1152/ajplegacy.1957.191.3.591. [DOI] [PubMed] [Google Scholar]
  21. Schimpff S., Satterlee W., Young V. M., Serpick A. Empiric therapy with carbenicillin and gentamicin for febrile patients with cancer and granulocytopenia. N Engl J Med. 1971 May 13;284(19):1061–1065. doi: 10.1056/NEJM197105132841904. [DOI] [PubMed] [Google Scholar]
  22. Watanakunakorn C. Comparative in vitro activity of Sch 20656, netilmicin, gentamicin, and tobramycin. Antimicrob Agents Chemother. 1976 Aug;10(2):382–383. doi: 10.1128/aac.10.2.382. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Weinstein M. J., Marquez J. A., Testa R. T., Wagman G. H., Oden E. M., Waitz J. A. Antibiotic 6640, a new Micromonospora-produced aminoglycoside antibiotic. J Antibiot (Tokyo) 1970 Nov;23(11):551–554. doi: 10.7164/antibiotics.23.551. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES